2LSJ

Solution structure of the mouse Rev1 CTD in complex with the Rev1-interacting Region (RIR)of Pol Kappa

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.7-1 mM [U-100% 15N] protein, 0.7-1 mM [U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
2	2D 1H-13C HSQC	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
3	3D HNCA	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
4	3D HN(CO)CA	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
5	3D HNCACB	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
6	3D HN(COCA)CB	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
7	3D HA(CA)NH	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
8	3D HA(CACO)NH	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
9	3D HNCO	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
10	3D (HCA)CO(CA)NH	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
11	4D HCCH-TOCSY	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	100% D2O	0.1	7.0	ambient	310
12	4D HCCONH-TOCSY	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	100% D2O	0.1	7.0	ambient	310
13	3D 1H-15N NOESY	0.7-1 mM [U-100% 15N] protein, 0.7-1 mM [U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
14	3D 1H-13C NOESY	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	100% D2O	0.1	7.0	ambient	310
15	4D 13C-HMQC-NOESY-15N-HSQC	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	90% H2O/10% D2O	0.1	7.0	ambient	310
16	4D 13C-HMQC-NOESY-13C-HSQC	0.7-1 mM [U-100% 13C; U-100% 15N] protein, 0.7-1 mM [U-100% 13C; U-100% 15N] peptide, 25 mM sodium phosphate, 100 mM potassium chloride, 10 mM DTT, 1 mM EDTA	100% D2O	0.1	7.0	ambient	310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		TALOS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	TALOS		Cornilescu, Delaglio and Bax
2	data analysis	Sparky		Goddard
3	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
4	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.